Sebastian Krawiec is Editor at Nutritional Outlook.
Congressman filed amendment to ensure funds for CBD regulation in appropriations bill, reports NPA
June 18th 2019NPA has announced that its lobbying efforts have resulted in Representative Jerry McNerney (D-CA) filing an amendment to modify the House Agriculture appropriations bill to include the critical funds for FDA to establish safe use levels for CBD products.
New pea and canola protein blends from Burcon boast protein quality that challenges meat and dairy
June 13th 2019Burcon has introduced new pea and canola protein blends for plant-based dairy and meat alternatives. The firm has also announced a joint venture to open a C$65 million production facility to process 20,000 tons of plant protein per year.
Newly introduced bill will make dietary supplements eligible for purchase through SNAP benefits
June 6th 2019Senators Tim Scott (R-SC) and Kyrsten Sinema (D-AZ), as well as Representatives Tony Cárdenas (D-CA) and Mike Rogers (R-AL) have introduced a bill called The SNAP Vitamin and Mineral Improvement Act of 2019.
UNPA and HIA sign memorandum of understanding to advance hemp extract research, safety, and quality
June 6th 2019The United Natural Products Alliance and Hemp Industries Association have signed a memorandum of understanding agreement in an effort to advance hemp extract product research, safety, identity, and quality standards.
Supplement industry to FDA on CBD regulations: “We can’t wait years”
May 31st 2019At FDA’s highly anticipated public hearing on hemp cannabidiol (CBD) today, May 31, the message from dietary supplement industry representatives was clear: The supplement industry needs a regulatory pathway for CBD-and needs it now.
GOED and UNPA to host a webinar about mitigating intentional adulteration under FSMA
May 29th 2019GOED, in conjunction with its sister organization UNPA, will be hosting a webinar about FDA’s draft guidance on mitigation strategies to protect food against intentional adulteration, a part of the Food Safety and Modernization Act.
A major double-blind, placebo-controlled trial will study CBD on joint mobility in dogs
May 29th 2019The largest scale trial conducted on pets to have commenced to date, the trial will evaluate the effectiveness of hemp-based natural supplements on joint mobility in dogs suffering from inflammation secondary to osteoarthritis.